Worawit Kattipatanapong, MD, Ithipon Viratanapanu, MD, Sikarin Sornphiphatphong, MD, Kongpon Tangpanitandee, MD, Krit Kitisin, MD, Suppa-ut Pungpapong, MD, Chadin Tharavej, MD, Patpong Navicharern, MD, Suthep Udomsawaengsup, MD. King Chulalongkorn Memorial Hospital
Background: Morbid obesity patients have a high prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. The incidence is varied. We evaluated the prevalence and predictor of NAFLD/NASH in morbid obesity patient who undergoing bariatric surgery
Method: Retrospective review From January 2014 to August 2017 , In morbid obesity patient who undergoing bariatric surgery. Liver biopsy was performed before end of operation. The study variables include age, gender, weight, body mass index, body fat percentage, comorbidity, and blood chemistry from preoperative assessment
Result: 95 patients (48 males and 47 females) were analyzed. The mean age was 35.7±10.7. The mean body mass index was 50.9±11.9. among 95 patients, 85 (83.3%) patients had nonalcoholic fatty liver disease and 17 (17.9%) patients had nonalcoholic steatohepatitis. On univariate analysis, DM, body fat percentage, FBS, HbA1C, TSH, Platelets were correlated with presence NASH. On multivariate analysis, there no one of parameter had statistical significance.
Conclusion: the prevalence of NAFLD and NASH in patient who undergoing bariatric surgery was 83.3% and 17.9% respectively. In this study , there no strong predictor correlated with presence NASH.
Presented at the SAGES 2017 Annual Meeting in Houston, TX.
Abstract ID: 86778
Program Number: P650
Presentation Session: iPoster Session (Non CME)
Presentation Type: Poster
sages_adbutler_leaderboard